Michigan Medicine: CAR T-cell and Cellulary Therapy
April 15, 2026
April 15, 2026
ANN ARBOR, Michigan, April 15 -- Michigan Medicine, the academic medical center of the University of Michigan, issued the following news release about a podcast:
* * *
CAR T-cell and Cellulary Therapy
NOTE: This podcast first aired in 2018. As of 2026, CAR T-cell Therapy is used for lymphoma, ALL, Multiple Myeloma (refractory and metastatic). To learn more about this treatment, please visit our CAR T-cell Therapy webpage (https://www.uofmhealth.org/our-care . . .
* * *
CAR T-cell and Cellulary Therapy
NOTE: This podcast first aired in 2018. As of 2026, CAR T-cell Therapy is used for lymphoma, ALL, Multiple Myeloma (refractory and metastatic). To learn more about this treatment, please visit our CAR T-cell Therapy webpage (https://www.uofmhealth.org/our-care . . .